Rh
RH · NYSE
1/31/2025 | 1/31/2024 | 1/31/2023 | 1/31/2022 | |
|---|---|---|---|---|
| Revenue | $3,181 | $3,029 | $3,590 | $3,759 |
| % Growth | 5% | -15.6% | -4.5% | – |
| Cost of Goods Sold | $1,766 | $1,640 | $1,778 | $1,903 |
| Gross Profit | $1,415 | $1,389 | $1,812 | $1,855 |
| % Margin | 44.5% | 45.9% | 50.5% | 49.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $939 | $898 | $1,019 | $888 |
| SG&A Expenses | $1,061 | $1,005 | $1,090 | $928 |
| Sales & Mktg Exp. | $122 | $107 | $71 | $40 |
| Other Operating Expenses | $31 | $0 | -$0 | -$3 |
| Operating Expenses | $1,092 | $1,023 | $1,090 | $928 |
| Operating Income | $323 | $366 | $722 | $927 |
| % Margin | 10.1% | 12.1% | 20.1% | 24.7% |
| Other Income/Exp. Net | -$245 | -$210 | -$283 | -$105 |
| Pre-Tax Income | $77 | $156 | $439 | $822 |
| Tax Expense | $5 | $28 | -$91 | $134 |
| Net Income | $72 | $128 | $529 | $689 |
| % Margin | 2.3% | 4.2% | 14.7% | 18.3% |
| EPS | 3.92 | 6.42 | 22.47 | 32.37 |
| % Growth | -38.9% | -71.4% | -30.6% | – |
| EPS Diluted | 3.62 | 5.91 | 19.9 | 22.13 |
| Weighted Avg Shares Out | 18 | 20 | 24 | 21 |
| Weighted Avg Shares Out Dil | 20 | 22 | 27 | 31 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4 | $40 | $39 | $2 |
| Interest Expense | $235 | $238 | $152 | $67 |
| Depreciation & Amortization | $130 | $119 | $184 | $169 |
| EBITDA | $453 | $524 | $775 | $1,066 |
| % Margin | 14.3% | 17.3% | 21.6% | 28.4% |